HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India

L Ray Saraswati, A Sarna, MP Sebastian, V Sharma… - BMC public health, 2015 - Springer
Background India has large PWID (persons who inject drugs) population estimated at
177,000. PWIDs are at high risk for HIV, Hepatitis B (HBV) and Hepatitis C (HCV) infections …

A pilot study to expand treatment of chronic hepatitis C in resource-limited settings

P Mathur, E Comstock, E McSweegan, N Mercer… - Antiviral Research, 2017 - Elsevier
The past five years have seen a revolution in the treatment of chronic hepatitis C, as short
duration oral regimens of direct-acting antiviral drugs (DAAs), with nearly 100% cure rates …

Marijuana use is not associated with progression to advanced liver fibrosis in HIV/hepatitis C virus–coinfected women

EM Kelly, JL Dodge, M Sarkar, AL French… - Reviews of Infectious …, 2016 - academic.oup.com
Abstract Background. Marijuana (hereafter “tetrahydrocannabinol [THC]”) use has been
associated with liver fibrosis progression in retrospective analyses of patients with chronic …

Comparative assessment of liver fibrosis in patients with HIV/chronic hepatitis C co-infection in different ethnic groups

N Sarsekeyeva, B Kosherova, I Azizov - The Journal of Infection in …, 2016 - jidc.org
Introduction: In recent years, the frequency of human immunodeficiency virus (HIV) and
hepatitis C (HCV) co-infection has increased, which is due to their common routes of …

[HTML][HTML] Liver fibrosis recognition using multi-compression elastography technique

AA Wahba, NMM Khalifa, AF Seddik… - Journal of Biomedical …, 2013 - scirp.org
Liver fibrosis recognition is an important issue in diagnostic imaging. The accurate
estimation of liver fibrosis stages is important to establish prognosis and to guide …

[HTML][HTML] Liver stiffness is not associated with short-and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV …

SG Parisi, M Basso, C Mengoli… - Annals of …, 2017 - ncbi.nlm.nih.gov
Background Human immunodeficiency virus (HIV) may be directly responsible for liver
damage but there are contrasting data regarding the influence of detectable plasma viremia …

The impact of DAA treatment on HIV/HCV co-infected individuals across Europe: Analyses of co-infection data from a European cohort study

S Amele - 2021 - discovery.ucl.ac.uk
With the introduction of safe and highly efficacious direct-acting antivirals (DAAs),
elimination of HCV has become more viable. The World Health Organisation set the targets …

[HTML][HTML] Management of Hepatitis C in Patients With HIV

N Blattman - Federal Practitioner, 2015 - ncbi.nlm.nih.gov
Management of Hepatitis C in Patients With HIV - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

[PDF][PDF] Sustained Virologic Response Rates of Direct Acting Antivirals in HIV Coinfected Hepatitis C Patients and Its Effect on Liver Fibrosis

L Dora, S Alexandra, L Alicia… - … Journal of Clinical …, 2020 - pdfs.semanticscholar.org
Abstract Background: Hepatitis C virus (HCV) is an important cause of chronic hepatitis with
necroinflammation and fibrosis resulting in end stage liver disease and hepatocellular …

Characterization of demographic, behavioral, immunologic, and virologic factors associated with incident and prevalent hepatitis C virus infection among HIV-infected …

E Maina - 2016 - search.proquest.com
Recent reports around the world show that hepatitis C virus (HCV) infection rates among
human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) have …